Cargando…

Down-regulation of Enhancer of Zeste-2 decreases growth of estrogen receptor negative invasive breast carcinoma and requires BRCA1

Increased levels of EZH2, a critical regulator of cellular memory, are associated with negative estrogen receptor (ER) expression and disease progression in breast cancer. High levels of EZH2 signal the presence of metastasis and poor outcome in breast cancer patients. To test the hypothesis that de...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gonzalez, Maria E., Li, Xin, Toy, Katherine, DuPrie, Matthew, Ventura, Alejandra C., Banerjee, Mousumi, Ljugman, Mats, Merajver, Sofia D., Kleer, Celina G.
Formato:	Texto
Lenguaje:	English
Publicado:	2008
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2643353/ https://www.ncbi.nlm.nih.gov/pubmed/19079346 http://dx.doi.org/10.1038/onc.2008.433

Ejemplares similares

RhoC Impacts the Metastatic Potential and Abundance of Breast Cancer Stem Cells
por: Rosenthal, Devin T., et al.
Publicado: (2012)

Molecular biology of breast cancer metastasis: Inflammatory breast cancer: clinical syndrome and molecular determinants
por: Kleer, Celina G, et al.
Publicado: (2000)

Inhibition of CCN6 (WISP3) expression promotes neoplastic progression and enhances the effects of insulin-like growth factor-1 on breast epithelial cells
por: Zhang, Yanhong, et al.
Publicado: (2005)

The unstructured linker of Mlh1 contains a motif required for endonuclease function which is mutated in cancers
por: Torres, Kendall A., et al.
Publicado: (2022)

WISP3 and RhoC guanosine triphosphatase cooperate in the development of inflammatory breast cancer
por: Kleer, Celina G, et al.
Publicado: (2004)

Chronic Mastitis in Egypt and Morocco: Differentiating between Idiopathic Granulomatous Mastitis and IgG4‐Related Disease
por: Allen, Steven G., et al.
Publicado: (2016)

Mlh1 interacts with both Msh2 and Msh6 for recruitment during mismatch repair
por: DuPrie, Matthew L., et al.
Publicado: (2022)

Healthcare access and mammography screening in Michigan: a multilevel cross-sectional study
por: Akinyemiju, Tomi F, et al.
Publicado: (2012)

Trends in Breast Cancer Stage and Mortality in Michigan (1992–2009) by Race, Socioeconomic Status, and Area Healthcare Resources
por: Akinyemiju, Tomi F., et al.
Publicado: (2013)

Enhancer of Zeste Homologue 2 (EZH2) Down-regulates RUNX3 by Increasing Histone H3 Methylation
por: Fujii, Satoshi, et al.
Publicado: (2008)

A Hidden Feedback in Signaling Cascades Is Revealed
por: Ventura, Alejandra C., et al.
Publicado: (2008)

Retroactive Signaling in Short Signaling Pathways
por: Sepulchre, Jacques-Alexandre, et al.
Publicado: (2012)

Androgen Receptor and ALDH1 Expression Among Internationally Diverse Patient Populations
por: Jiagge, Evelyn, et al.
Publicado: (2018)

BRCA1 And Estrogen/Estrogen Receptor In Breast Cancer: Where They Interact?
por: Wang, Li, et al.
Publicado: (2014)

Enhancer of zeste homolog 2 is involved in the proliferation of endometrial carcinoma
por: JIA, NAN, et al.
Publicado: (2014)

The matricellular protein CCN6 (WISP3) decreases Notch1 and suppresses breast cancer initiating cells
por: Huang, Wei, et al.
Publicado: (2016)

Transactivation of the estrogen receptor promoter by BRCA1
por: Archey, William B., et al.
Publicado: (2017)

Decreased BRCA1 Confers Tamoxifen Resistance in Breast Cancer Cells by Altering Estrogen Receptor-Coregulator Interactions
por: Wen, Jie, et al.
Publicado: (2008)

Multisite Phosphorylation Provides an Effective and Flexible Mechanism for Switch-Like Protein Degradation
por: Varedi K., S. Marjan, et al.
Publicado: (2010)

Oncogenic roles of enhancer of zeste homolog 1/2 in hematological malignancies
por: Nakagawa, Makoto, et al.
Publicado: (2018)

Predominance of BRCA2 Mutation and Estrogen Receptor Positivity in Unselected Breast Cancer with BRCA1 or BRCA2 Mutation
por: Pujol, Pascal, et al.
Publicado: (2022)

Estrogen promotes estrogen receptor negative BRCA1-deficient tumor initiation and progression
por: Wang, Chuying, et al.
Publicado: (2018)

Individual and Neighborhood Socioeconomic Status and Healthcare Resources in Relation to Black-White Breast Cancer Survival Disparities
por: Akinyemiju, Tomi F., et al.
Publicado: (2013)

Suppressor of Zeste 12 homolog RNA interference inhibits retinoblastoma cell invasion
por: ZHOU, MIN, et al.
Publicado: (2014)

Enhancer of zeste acts as a major developmental regulator of Ciona intestinalis embryogenesis
por: Le Goff, Emilie, et al.
Publicado: (2015)

Targeting enhancer of zeste homolog 2 protects against acute kidney injury
por: Zhou, X., et al.
Publicado: (2018)

Impact of Enhancer of Zeste Homolog 2 on T Helper Cell-Mediated Allergic Rhinitis
por: Hou, Tsung-Yun, et al.
Publicado: (2017)

Clinicopathological Analysis of Expression of Enhancer of Zeste Homologue 2 in Canine Mammary Carcinoma
por: Ren, Xiaoli, et al.
Publicado: (2022)

Life Satisfaction and Character Strengths in Women With Breast Cancer: Zest and Hope as Predictors
por: Soria-Reyes, Lorena M., et al.
Publicado: (2023)

Estrogen receptor transcription and transactivation: Genetic modifiers of cancer risks conferred by BRCA1 and BRCA2
por: Devilee, P
Publicado: (2001)

Kinase inhibitors can produce off-target effects and activate linked pathways by retroactivity
por: Wynn, Michelle L, et al.
Publicado: (2011)

BRCA1 directly modulates gene expression required for estrogen biosynthesis: a possible mechanism of tissue-specific tumor suppression
por: Hu, Y, et al.
Publicado: (2005)

Enhancer of Zeste Homolog 2 Induces Pulmonary Artery Smooth Muscle Cell Proliferation
por: Aljubran, Salman A., et al.
Publicado: (2012)

Enhancer of Zeste Homolog 2 as an Independent Prognostic Marker for Cancer: A Meta-Analysis
por: Chen, Shuling, et al.
Publicado: (2015)

Enhancer of zeste homolog 2 silencing inhibits tumor growth and lung metastasis in osteosarcoma
por: Lv, Yang-Fan, et al.
Publicado: (2015)

Enhancer of zeste homolog 2 promotes cisplatin resistance by reducing cellular platinum accumulation
por: Sun, Si, et al.
Publicado: (2018)

Enhancer of Zeste homolog 2 (EZH2) induces epithelial-mesenchymal transition in endometriosis
por: Zhang, Qi, et al.
Publicado: (2017)

Enhancer of zeste homolog 2 enhances the migration and chemotaxis of dental mesenchymal stem cells
por: Ma, Huarui, et al.
Publicado: (2019)

Comprehensive Analysis of the Expression Characteristics of the Enhancer of the Zeste Homolog 2 Gene in Pan-Cancer
por: Kang, Yuanyuan, et al.
Publicado: (2021)

Expression of Enhancer of Zeste Homolog 2 (EZH2) Gene in Acute Myeloid Leukemia
por: Hamed, Nahla A. M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8lmldtml5l33cdb7dqjf8gq45j